GeekWire
Menu
  • Home
  • News
    • Amazon
    • Civic presented by Microsoft
    • Geek Life presented by Network of Giving
    • Health/Life Sciences
    • Microsoft
    • Podcasts
    • Space
    • Startups
    • Sustainability
    • Tech Moves
    • Bot or Not
    • GeekWire on the Road: Spokane
    • Microsoft at 50 presented by Accenture
    • Tech Vets presented by Northern Trust
  • GeekWork
    • GeekWork Recruiting
    • Job Board
  • Events
    • Community Calendar
    • GeekWire Events
  • Lists
    • Amazon Office Buildings
    • GeekWire 200 presented by JPMorganChase
    • GeekWire Startup List
    • GeekWire Startup Resources
    • GeekWire Startup Spaces
    • Layoff Tracker
    • M&As and IPOs
    • Northwest Women VC & Angel Investor List
    • Recent Fundings
    • Seattle Engineering Outposts
    • Venture Capital Directory
  • Members
    • Health Benefits
    • Memberships
  • Studios
    • GeekWire Studios: Let Us Tell Your Story
    • Nebius at NVIDIA GTC 2025 sponsored by Nebius
    • AWS Marketplace Seller Conference 2024 sponsored by AWS
    • AWS Summit: New York Partner Spotlights sponsored by AWS
    • Does Compute presented by Carnegie Mellon University
    • Guide to re:Invent sponsored by AWS
    • Money Hacks presented by BECU
    • Tech Connect at Dreamforce 2024 sponsored by RSM US LLP
    • Uncommon Thinkers Welcome sponsored by Greater Seattle Partners
    • Zuper at Inbound sponsored by Zuper
  • About
    • About GeekWire
    • Advertise
    • Contact Us
    • Email Newsletters
    • Reprints & Permissions
    • Sponsors
  • Podcast
  • LinkedIn
  • Newsletter
  • News Tips

What happens here matters everywhere.

  • Podcast
  • LinkedIn
  • Newsletter
  • News Tips
  • Amazon
  • Microsoft
  • Startups
  • AI
  • Science
  • Tech Moves
  • Sustainability
  • Civic
  • Geek Life

Health/Life Sciences

Secretive Seattle biotech company raises more than $700M to develop new ways to modify genes

Sana Biotechnology today formally announced that it has raised more than $700 million in venture funding — one of the… Read More

Drug combination

Institute halts COVID-19 clinical trial for hydroxychloroquine due to low enrollment

The National Institute of Allergy and Infectious Diseases has shut down a clinical trial to see if a combination of… Read More

Seattle area sees new spike in COVID-19 cases, weekly count up for 1st time in more than 2 months

More than 400 new cases of COVID-19 were reported in Seattle and King County in the past week, up nearly… Read More

Alpine Immune Sciences stock rises after biotech firm lands $60M from AbbVie for lupus drug

Alpine Immune Sciences stock rose more than 10% Friday after the Seattle-based biotech company inked a $60 million licensing deal… Read More

WA Food Fund at work

Paul G. Allen Family Foundation donates $2.2M to COVID-19 causes (with an assist from Amazon)

The Paul G. Allen Family Foundation announced two contributions to support people affected by the COVID-19 pandemic in Washington state,… Read More

The next X-ray? Seattle startup Proprio raises $23M to build high-tech surgical navigation system

Seattle startup Proprio has raised more cash to help build out its surgical technology that some investors believe will be… Read More

At-home test kit

Researchers want to pick up the pace on early testing and treatment for COVID-19

Scientists from Seattle’s Fred Hutchinson Cancer Research Center and the University of Washington say the search for COVID-19 treatments should… Read More

Coronavirus

British study suggests that a low-cost steroid could reduce COVID-19 death rate

A study involving thousands of COVID-19 patients in Britain suggests that a low-cost steroid drug known as dexamethasone could significantly… Read More

IHME and C19Pro projections

COVID-19 projections show higher death tolls ahead as restrictions are lifted

The latest projections for the course of the coronavirus pandemic in the U.S. suggest that there’s going to be an… Read More

Hydroxychloroquine pills on lung X-ray

FDA ends authorization to use hydroxychloroquine for COVID-19 and issues warning, but trials go on

The Food and Drug Administration today revoked its emergency authorization for two related antimalarial drugs, chloroquine and hydroxychloroquine, to be… Read More

Medical device repair startup Summit Imaging fires back at Philips over device ‘hacking’ claims

Seattle-area medical device repair company Summit Imaging is denying accusations of hacking and stolen trade secrets in a court battle… Read More

COVID-19 transmission in Seattle region rises back above key threshold, new estimates show

Transmission of COVID-19 is back on the rise in the Seattle region and other parts of Washington state, again exceeding… Read More

Latest testing shows no big spike in COVID-19 cases due to protests, as thousands wear masks

Seattle Mayor Jenny Durkan’s office says it’s seeing no evidence so far that protesters are testing positive for COVID-19 at… Read More

Evolution of coronavirus in U.S.

Amid COVID-19 pandemic, experts lay out 10-point plan for a genomic revolution in public health

From the early days of the coronavirus pandemic, genetic sleuths have been at the forefront in the global effort to… Read More

Immune system activity

Adaptive Biotechnologies and Microsoft team up to track coronavirus-fighting cells

https://www.youtube.com/watch?v=gro9DtSKqos Seattle-based Adaptive Biotechnologies and Microsoft have launched an open-access database called ImmuneCODE to catalog the many ways in which… Read More

Virtual care provider Conversa raises $12M as investors bet big on digital health startups

The latest digital health company to land funding is Conversa, a Portland, Ore.-based telehealth startup that announced a $12 million… Read More

Sample testing

SCAN resumes community coronavirus testing after winning review board’s OK

The Seattle Coronavirus Assessment Network today resumed its at-home COVID-19 testing campaign, nearly a month after the program was suspended… Read More

Comparative coronavirus charts

Coronavirus projections converge amid concerns about a pandemic resurgence

Dueling projections for the course of the COVID-19 pandemic are converging on a narrower range of estimates for this summer,… Read More

Researchers gauge the effect of protests and reopenings on reviving the pandemic

Epidemiologists say the crowding conditions associated with mass protests over police violence seem likely to add dozens of people, or… Read More

Larry Corey

Vaccine veterans preview milestones on the long road to the end of the pandemic

A public-private partnership called Operation Warp Speed is aiming to get multiple vaccines approved by the end of the year… Read More

Chinook Therapeutics to merge with Aduro Biotech as it pushes forward with kidney disease therapies

Chinook Therapeutics, a biotech company creating targeted therapies for kidney diseases, has agreed to merge with Berkeley, Calif.-based Aduro Biotech.… Read More

WHO director-general

WHO resumes using hydroxychloroquine in COVID trial; discouraging study retracted due to doubts

After a weeklong review of safety data, the World Health Organization announced today that it’s ending a “pause” in the… Read More

Peter Hotez and Maria Elena Bottazzi

Infectious Disease Research Institute is working on a multiplier effect for coronavirus vaccine

Seattle’s Infectious Disease Research Institute is working with Houston’s Baylor College of Medicine to multiply the doses of a potential… Read More

Sen. Maria Cantwell co-sponsors bill to shield privacy in COVID-19 contact tracing

Sen. Maria Cantwell, D-Wash., is one of the sponsors of bipartisan legislation aimed at ensuring that coronavirus tracing apps protect… Read More

Ventec and GM, 2 months later: How a startup took on the ventilator shortage, and where it stands now

Two months after President Donald Trump tapped a little-known Seattle-area medical device startup called Ventec Life Systems and automotive giant… Read More

Protests and COVID-19

Health experts seek to balance community concerns and coronavirus concerns

Public health officials for Seattle and King County today acknowledged the seriousness of the crisis sparked by last week’s killing… Read More

‘Start innovating like crazy’: Fast-moving genomics startup turns to R&D to navigate the pandemic

On the day in early March when I interviewed Phase Genomics CEO Ivan Liachko, we knew just enough about the… Read More

Nextstrain

Researchers revise their timeline for the coronavirus’ rise in Washington state

Epidemiologists are coming around to the view that the first confirmed case of COVID-19 in the U.S., involving a Snohomish… Read More

Telemedicine startup Bright.md raises more cash as interest in virtual healthcare surges

Portland, Ore.-based startup Bright.md officially closed a $16.7 million investment round for its AI-powered virtual healthcare service. GeekWire previously reported… Read More

A-Alpha Bio scientist Emily Engelhart

A-Alpha Bio wins $620,000 grant to work on ‘molecular glue’ for treating disease

A-Alpha Bio, a Seattle venture that began at the University of Washington, has won a $620,472 grant from the National… Read More

  • Older
  • Newer

Latest Stories

    Read All Stories

    GeekWire Newsletters

    Subscribe to GeekWire's free newsletters to catch every headline

    Send Us a Tip

    Have a scoop that you'd like GeekWire to cover? Let us know.

    Send Us a Tip

    A Word From Our Sponsors

    About

    • About GeekWire
    • Contact Us
    • Partner With Us
    • Become a GeekWire Member
    • Send Us a Tip
    • Join Our Startup List
    • Reprints and Permissions

    Follow

    • Facebook
    • X
    • LinkedIn
    • Instagram
    • RSS Feed
    • Podcast
    • YouTube
    • Bluesky

    GeekWire Newsletters

    Catch every headline in your inbox

    Read GeekWire

    • Apple News
    • Google News

    Legal

    • Privacy Policy
    • Terms of Use
    • Sponsored Content Policy
    Return to Top of Page
    © 2011-2025 GeekWire, LLC
    Do Not Sell or Share My Personal information
    Limit the Use Of My Sensitive Personal Information
    Consent Preferences